Literature DB >> 23340085

Sleep apnea in precapillary pulmonary hypertension.

Rio Dumitrascu1, Henning Tiede, Jan Eckermann, Konstantin Mayer, Frank Reichenberger, Hossein Ardeschir Ghofrani, Werner Seeger, Jörg Heitmann, Richard Schulz.   

Abstract

OBJECTIVES: Pilot studies have described the occurrence of sleep apnea in patients with precapillary pulmonary hypertension (PH). However, there are no data on the prevalence of sleep-related breathing disorders in larger patient cohorts with PH.
METHODS: 169 patients with a diagnosis of PH confirmed by right heart catheterisation and clinically stable in NYHA classes II or III were prospectively investigated by polygraphy (n = 105 females, mean age: 61.3 years, mean body mass index: 27.2 kg/m(2)). Recruitment was independent of sleep-related symptoms and the use of vasodilator drugs or nasal oxygen.
RESULTS: 45 patients (i.e. 26.6%) had an apnea-hypopnea-index (AHI) >10/h. Of these, 27 patients (i.e. 16%) had obstructive sleep apnea (OSA) and 18 patients (i.e. 10.6%) had central sleep apnea (CSA). The mean AHI was 20/hour. As a polygraphy had been performed with nasal oxygen in half of the patients without evidence for sleep apnea, the frequency of CSA was probably underestimated. Patients with OSA were characterized by male gender and higher body mass index whereas, those with CSA were older and hypocapnic.
CONCLUSIONS: At least every fourth patient with PH suffers from mild-to-moderate sleep apnea. Considering the anthropometric characteristics of the patients studied, the prevalence of both OSA and CSA seem to be higher in PH than in the general population.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23340085     DOI: 10.1016/j.sleep.2012.11.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  21 in total

Review 1.  Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.

Authors:  Cyrus Kholdani; Wassim H Fares; Vahid Mohsenin
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Sleep disordered breathing in group 1 pulmonary arterial hypertension.

Authors:  Milan Minic; John T Granton; Clodagh M Ryan
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

3.  Derivation of a screening tool to identify patients with right ventricular dysfunction or tricuspid regurgitation after negative computerized tomographic pulmonary angiography of the chest.

Authors:  Jeffrey A Kline; Frances M Russell; Tim Lahm; Ronald A Mastouri
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

4.  Platypnea-orthodeoxia syndrome due to patent foramen ovale. An unusual cause of Cheyne-Stokes respiration.

Authors:  T Bitter; L Faber; W Scholz; H Fox; C Prinz; D Horstkotte; O Oldenburg
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

5.  Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis.

Authors:  Eldrin F Lewis; Rui Wang; Naresh Punjabi; Daniel J Gottlieb; Stuart F Quan; Deepak L Bhatt; Sanjay R Patel; Reena Mehra; Roger S Blumenthal; Jia Weng; Michael Rueschman; Susan Redline
Journal:  Am Heart J       Date:  2017-03-14       Impact factor: 4.749

6.  Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial.

Authors:  Thomas Bitter; Henrik Fox; Heidi Schmalgemeier; Birgit Wellmann; Andrea Zwenke; Jens Spiesshöfer; Zisis Dimitriadis; Dieter Horstkotte; Olaf Oldenburg
Journal:  Sleep Breath       Date:  2016-01-19       Impact factor: 2.816

7.  Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath.

Authors:  Frances M Russell; Christopher L Moore; D Mark Courtney; Christopher Kabrhel; Howard A Smithline; Kristen E Nordenholz; Peter B Richman; Brian J O'Neil; Michael C Plewa; Daren M Beam; Ronald Mastouri; Jeffrey A Kline
Journal:  Am J Emerg Med       Date:  2015-01-22       Impact factor: 2.469

Review 8.  Sleep apnea, heart failure, and pulmonary hypertension.

Authors:  Sogol Javaheri; Shahrokh Javaheri; Ali Javaheri
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  Usefulness of Low Cardiac Index to Predict Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jeremy E Orr; William R Auger; Pamela N DeYoung; Nick H Kim; Atul Malhotra; Robert L Owens
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

Review 10.  The epidemiology of obstructive sleep apnoea and cardiovascular disease.

Authors:  Paroma Sarkar; Sutapa Mukherjee; Ching Li Chai-Coetzer; R Doug McEvoy
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.